CDK4 and cancer: Moreover, CDK4/6i treatment in MP41 cells led to noticeable Rb-protein reduction before the emergence of persisters (Fig. 6a, b), suggesting the contribution of Rb-protein reduction to CDK4/6i adaptation in cancer cells.